Joseph E. Tomaszewski
Impact in
- Oncology top 1%
- PARP inhibition in cancer therapy
- Cancer Research top 2%
- Carcinogens and Genotoxicity Assessment
- Cancer Genomics and Diagnostics
Papers in
-
- Cancer therapeutics and mechanisms 27
- DNA Repair Mechanisms 11
- Oncology 50
- PARP inhibition in cancer therapy 17
- Cancer Cells and Metastasis 10
- Co-authors
- James H. Doroshow (69 shared papers)Ralph E. Parchment (59 shared papers)Robert J. Kinders (48 shared papers)Shivaani Kummar (32 shared papers)Larry Rubinstein (22 shared papers)Edward A. Sausville (4 shared papers)Anthony Dipple (7 shared papers)C. Anita H. Bigger (6 shared papers)
- Journals
- Cancer Research (21 papers)Journal of Clinical Oncology (15 papers)Molecular Cancer Therapeutics (10 papers)Clinical Cancer Research (9 papers)Cancer Chemotherapy and Pharmacology (9 papers)
- Partner nations
- United StatesMalaysiaUkraine
In The Last Decade
Joseph E. Tomaszewski
144 papers receiving 4.7k citations
Peers
Comparison fields: 5 of 134
- Oncology 1.5k
- Cancer Research 788
- Molecular Biology 2.3k
- Pharmacology 276
- Toxicology 98
Countries citing papers authored by Joseph E. Tomaszewski
This map shows the geographic impact of Joseph E. Tomaszewski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph E. Tomaszewski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph E. Tomaszewski more than expected).
Fields of papers citing papers by Joseph E. Tomaszewski
This network shows the impact of papers produced by Joseph E. Tomaszewski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph E. Tomaszewski. The network helps show where Joseph E. Tomaszewski may publish in the future.
Co-authors
The 25 scholars most cited alongside Joseph E. Tomaszewski, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 148 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 246 | |
| 2 | Expression of prolactin and prolactin receptor in human breast carcinoma. Evidence for an autocrine/paracrine loop. | 1995 | 227 |
| 3 | 2010 | 208 | |
| 4 | 2003 | 203 | |
| 5 | 2004 | 192 | |
| 6 | 2012 | 171 | |
| 7 | 2007 | 162 | |
| 8 | 1999 | 149 | |
| 9 | 2015 | 146 | |
| 10 | 1975 | 136 | |
| 11 | 2009 | 130 | |
| 12 | 2012 | 126 | |
| 13 | 2004 | 119 | |
| 14 | 1980 | 99 | |
| 15 | 2009 | 98 | |
| 16 | 2005 | 96 | |
| 17 | 1995 | 94 | |
| 18 | 1978 | 92 | |
| 19 | 1997 | 91 | |
| 20 | 2010 | 82 |
About Joseph E. Tomaszewski
Joseph E. Tomaszewski is a scholar working on Molecular Biology, Oncology, Cancer Research, Genetics and Infectious Diseases, having authored 148 papers that have together received 5.0k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (27 papers), PARP inhibition in cancer therapy (17 papers), DNA Repair Mechanisms (11 papers), Cancer Genomics and Diagnostics (11 papers), Cancer Cells and Metastasis (10 papers), Cancer, Hypoxia, and Metabolism (9 papers), Statistical Methods in Clinical Trials (8 papers) and Computational Drug Discovery Methods (7 papers). The work is most often cited by research in Oncology (1.5k citations), Cancer Research (788 citations), Molecular Biology (2.3k citations), Pharmacology (276 citations) and Toxicology (98 citations). Joseph E. Tomaszewski has collaborated with scholars based in United States, Malaysia and Ukraine. Frequent co-authors include James H. Doroshow, Ralph E. Parchment, Robert J. Kinders, Shivaani Kummar, Larry Rubinstein, Edward A. Sausville, Anthony Dipple, C. Anita H. Bigger, Beverly A. Teicher and Percy Ivy. Their work appears in journals such as Cancer Research, Journal of Clinical Oncology, Molecular Cancer Therapeutics, Clinical Cancer Research and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.